Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Biofrontera Inc. (BFRI) Stock Falls on Q3 2026 Earnings

None

Biofrontera Inc. (BFRI) reported third-quarter 2026 revenue of $9.1 million, up nearly 30% from a year earlier and above analyst expectations of $8.7 million. Gross profit also improved meaningfully to $6.7 million, reflecting stronger top-line performance.

Profitability remained under pressure, however, as the company posted an operating loss of $6.5 million and a net loss attributable to common shareholders of $6.4 million. Diluted loss per share came in at $0.42, compared with an estimate of $0.11 per share.

Cash generation also stayed negative, with operating cash flow of -$1.4 million. Biofrontera ended the quarter with $3.4 million in cash and cash equivalents, while total liabilities stood at $21.7 million.

  • Revenue: $9.1 million, up 29.8% year over year
  • Gross profit: $6.7 million, up 36.5% year over year
  • Operating loss: $6.5 million
  • Net loss: $6.4 million
  • Stock moved down 8.5% after the market close

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Biofrontera Inc. Hedge Fund Activity

We have seen 15 institutional investors add shares of Biofrontera Inc. stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles